Natalie Diep is a partner in the London office of Morrison & Foerster and is a member of the Corporate Group. Ms. Diep advises on a wide range of corporate issues including equity offerings, private placements, IPO's and mergers and acquisitions.

Ms. Diep spent a number of years at Weil, Gotshal & Manges and joined Morrison & Foerster in 2005 having spent a year as Legal Counsel for the Equity Capital Markets department of Lehman Brothers.

• advising Piper Jaffray in its capacity as underwriter and placement agent for Antisoma plc in the acquisition of Xanthus Pharmaceuticals Inc. and related fundraising;
• advising Acambis plc on its successful placing and open offer to raise £40 million;
• advising Collins Stewart in its capacity as sponsor and underwriter for Northwest Biotherapeutics Inc. on its successful IPO and fundraising on AIM;
• advising Amsterdam Molecular Therapeutics on its successful IPO on Euronext and related fundraising of €50 million;
• advising Ardana on its successful placing and open offer to raise £11 million;
• advising Silverjet plc on its successful IPO and further fundraisings on AIM;
• advising Renovo Group plc on its successful IPO on the Official List and related Global Offering of £50 million;
• advising Oxford Biomedica plc on a proposed placing and open offer and related investment by Sigma-Aldrich to raise £30.1 million;
• advising ReNeuron Group plc on its successful IPO on AIM; and
• advising Plethora Solutions plc on its successful IPO on AIM, and its subsequent fundraising in connection with its acquisition of Timm Medical.